Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients

• Status: Unknown status
• Trial end date: 2012-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the efficacy of umbilical cord mesenchymal stem cells (MSCs) infusion via hepatic artery in the treatment of liver cirrhosis.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Qingdao University

Criteria

Inclusion Criteria:

• Aged 18~70 years.

• Liver cirrhosis

• written consent

Exclusion Criteria:

• The end-stage of liver cirrhosis.

• Severe problems in other vital organs(e.g.the heart,renal or lungs).

• Hepatocellular carcinoma or other malignancies

• Pregnancy

• sepsis

• Presence of significant extrahepatic biliary disease (e.g. CBD stone, PSC, etc.)

• Cardiac, renal or respiratory failure

• Active thrombosis of the portal or hepatic veins